Adventitia contribution to vascular contraction: Hints provided by tissue-engineered substitutes

Cardiovascular Research

Volumn 75, Issue 4, 2007, Pages 669-678

  Auger, François A ^a,b   D'Orléans Juste, Pédro ^c   Germain, Lucie ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Adventitia; Blood vessel; Tissue engineering; Vascular tone

Indexed keywords

ADVENTITIAL DERIVED RELAXING FACTOR; AUTACOID; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; HORMONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ADVENTITIA; ATHEROSCLEROSIS; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; HYPERTROPHY; MYOFIBROBLAST; NERVE STIMULATION; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TISSUE ENGINEERING; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; CONNECTIVE TISSUE; CORONARY ARTERY DISEASE; CORONARY VESSELS; HUMANS; TISSUE ENGINEERING; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 34547759793     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.06.001     Document Type: Review

References (106)

1. L'Heureux N., Stoclet J.C., Auger F.A., Lagaud G.J., Germain L., and Andriantsitohaina R. A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. Faseb J 15 (2001) 515-524
2. An S.J., Boyd R., Zhu M., Chapman A., Pimentel D.R., and Wang H.D. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts. Cardiovasc Res 75 (2007) 702-709 10.1016/j.cardiores.2007.02.015
3. Laine P., Naukkarinen A., Heikkila L., Penttila A., and Kovanen P.T. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 101 (2000) 1665-1669
4. Wendel M., Kummer W., Knels L., Schmeck J., and Koch T. Muscular ETB receptors develop postnatally and are differentially distributed in specific segments of the rat vasculature. J Histochem Cytochem 53 (2005) 187-196
5. Yoshida K., Okamura T., Kimura H., Bredt D.S., Snyder S.H., and Toda N. Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries. Brain Res 629 (1993) 67-72
6. Zhang H., Du Y., Cohen R.A., Chobanian A.V., and Brecher P. Adventitia as a source of inducible nitric oxide synthase in the rat aorta. Am J Hypertens 12 (1999) 467-475
7. Mochizuki S., Goto M., Chiba Y., Ogasawara Y., and Kajiya F. Flow dependence and time constant of the change in nitric oxide concentration measured in the vascular media. Med Biol Eng Comput 37 (1999) 497-503
8. Beranova P., Schott C., Chalupsky K., Kleschyov A.L., Stoclet J.C., and Muller B. Role of the adventitia in the cyclic GMP-mediated relaxant effect of N-hydroxy-l-arginine in rat aorta. J Vasc Res 42 (2005) 331-336
9. Gonzalez M.C., Arribas S.M., Molero F., and Fernandez-Alfonso M.S. Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. Am J Physiol Heart Circ Physiol 280 (2001) H2876-H2881
10. Kleschyov A.L., Muller B., Keravis T., Stoeckel M.E., and Stoclet J.C. Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences. Am J Physiol Heart Circ Physiol 279 (2000) H2743-H2751
11. Kleschyov A.L., Muller B., Schott C., and Stoclet J.C. Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br J Pharmacol 124 (1998) 623-626
12. Levin J.A., and Wilson S.E. Effect of inhibitors of neuronal and extraneuronal uptake on the accumulation and metabolism of 3H-l-norepinephrine in rabbit aorta. Blood Vessels 20 (1983) 234-244
13. Lin L., Ding W.H., Jiang W., Zhang Y.G., Qi Y.F., Yuan W.J., et al. Urotensin-II activates l-arginine/nitric oxide pathway in isolated rat aortic adventitia. Peptides 25 (2004) 1977-1984
14. Mu H.M., Zhu Z.M., Wang H.Y., and Wang L.J. [Effect of removal of the adventitia on vascular remodeling and vasoconstriction in rabbits]. Sheng Li Xue Bao 55 (2003) 290-295
15. Kemler M.A., Kolkman W.F., Slootweg P.J., and Kon M. Adventitial stripping does not strip the adventitia. Plast Reconstr Surg 99 (1997) 1626-1631
16. Black A.F., Berthod F., L'Heureux N., Germain L., and Auger F.A. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. Faseb J 12 (1998) 1331-1340
17. Diebolt M., Germain L., Auger F.A., and Andriantsitohaina R. Mechanism of potentiation by polyphenols of contraction in human vein-engineered media. Am J Physiol Heart Circ Physiol 288 (2005) H2918-H2924
18. Dube J., Chakir J., Laviolette M., Saint Martin S., Boutet M., Desrochers C., et al. In vitro procollagen synthesis and proliferative phenotype of bronchial fibroblasts from normal and asthmatic subjects. Lab Invest 78 (1998) 297-307
19. Germain L., Auger F.A., Grandbois E., Guignard R., Giasson M., Boisjoly H., et al. Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology 67 (1999) 140-147
20. Germain L., Jean A., Auger F.A., and Garrel D.R. Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res 57 (1994) 268-273
21. Laflamme K., Roberge C.J., Grenier G., Remy-Zolghadri M., Pouliot S., Baker K., et al. Adventitia contribution in vascular tone: insights from adventitia-derived cells in a tissue-engineered human blood vessel. Faseb J 20 (2006) 1245-1247
22. Laflamme K., Roberge C.J., Labonte J., Pouliot S., D'Orleans-Juste P., Auger F.A., et al. Tissue-engineered human vascular media with a functional endothelin system. Circulation 111 (2005) 459-464
23. Laflamme K., Roberge C.J., Pouliot S.P., D'Orleans-Juste P., Auger F.A., and Germain L. Tissue-engineered human vascular media produced in vitro by the self-assembly approach present functional properties similar to those of their native blood vessels. Tissue Eng 12 (2006) 2275-2281
24. Laplante A.F., Germain L., Auger F.A., and Moulin V. Mechanisms of wound reepithelialization: hints from a tissue-engineered reconstructed skin to long-standing questions. Faseb J 15 (2001) 2377-2389
25. L'Heureux N., Paquet S., Labbe R., Germain L., and Auger F.A. A completely biological tissue-engineered human blood vessel. Faseb J 12 (1998) 47-56
26. Moulin V., Auger F.A., Garrel D., and Germain L. Role of wound healing myofibroblasts on re-epithelialization of human skin. Burns 26 (2000) 3-12
27. Paquette J.S., Moulin V., Tremblay P., Bernier V., Boutet M., Laviolette M., et al. Tissue-engineered human asthmatic bronchial equivalents. Eur Cell Mater 7 (2004) 1-11
28. Pouliot R., Germain L., Auger F.A., Tremblay N., and Juhasz J. Physical characterization of the stratum corneum of an in vitro human skin equivalent produced by tissue engineering and its comparison with normal human skin by ATR-FTIR spectroscopy and thermal analysis (DSC). Biochim Biophys Acta 1439 (1999) 341-352
29. Remy-Zolghadri M., Laganiere J., Oligny J.F., Germain L., and Auger F.A. Endothelium properties of a tissue-engineered blood vessel for small-diameter vascular reconstruction. J Vasc Surg 39 (2004) 613-620
30. Stoclet J.C., Andriantsitohaina R., L'Heureux N., Martinez C., Germain L., and Auger F. Use of human vessels and human vascular smooth muscle cells in pharmacology. Cell Biol Toxicol 12 (1996) 223-225
31. Talbot M., Carrier P., Giasson C.J., Deschambeault A., Guerin S.L., Auger F.A., Bazin R., et al. Autologous transplantation of rabbit limbal epithelia cultured on fibrin gels for ocular surface reconstruction. Mol Vis 12 (2006) 65-75
32. Tremblay P.L., Berthod F., Germain L., and Auger F.A. In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue. J Pharmacol Exp Ther 315 (2005) 510-516
33. Tremblay P.L., Hudon V., Berthod F., Germain L., and Auger F.A. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 5 (2005) 1002-1010
34. Rhodin J.A.G. Architecture of the vessel wall. In: Bohr D.F., Somlyo A.P., and Sparks H.V.J. (Eds). Handbook of physiology. Section 2: the cardiovascular system. Vol. II: vascular smooth muscle (1980), Am Physiol Soc, Bethesda, MD 1-31
35. Plante G.E. Vascular response to stress in health and disease. Metabolism 51 (2002) 25-30
36. Scotland R.S., Vallance P.J., and Ahluwalia A. Endogenous factors involved in regulation of tone of arterial vasa vasorum: implications for conduit vessel physiology. Cardiovasc Res 46 (2000) 403-411
37. Gutterman D.D. Adventitia-dependent influences on vascular function. Am J Physiol 277 (1999) H1265-H1272
38. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15 (1997) 323-350
39. Rey F.E., and Pagano P.J. The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 22 (2002) 1962-1971
40. Shao J.S., Cai J., and Towler D.A. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26 (2006) 1423-1430
41. Canfield A.E., Doherty M.J., Wood A.C., Farrington C., Ashton B., Begum N., et al. Role of pericytes in vascular calcification: a review. Z Kardiol 89 Suppl 2 (2000) 20-27
42. Wilkinson F.L., Liu Y., Rucka A.K., Jeziorska M., Hoyland J.A., Heagerty A.M., et al. Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol 211 (2007) 362-369
43. Lamalice L., Le Boeuf F., and Huot J. Endothelial cell migration during angiogenesis. Circ Res 100 (2007) 782-794
44. von Tell D., Armulik A., and Betsholtz C. Pericytes and vascular stability. Exp Cell Res 312 (2006) 623-629
45. Farrington-Rock C., Crofts N.J., Doherty M.J., Ashton B.A., Griffin-Jones C., and Canfield A.E. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110 (2004) 2226-2232
46. Yamashima T., Tonchev A.B., Vachkov I.H., Popivanova B.K., Seki T., Sawamoto K., et al. Vascular adventitia generates neuronal progenitors in the monkey hippocampus after ischemia. Hippocampus 14 (2004) 861-875
47. Engeli S. Is there a pathophysiological role for perivascular adipocytes?. Am J Physiol Heart Circ Physiol 289 (2005) H1794-H1795
48. Ford C.A., Mong K., and Tabrizchi R. Influence of tangential stress on mechanical responses to vasoactive agents in human saphenous vein with and without perivascular adipose tissue. Can J Cardiol 22 (2006) 1209-1216
49. Yudkin J.S., Eringa E., and Stehouwer C.D. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365 (2005) 1817-1820
50. Zalewski A., Shi Y., and Johnson A.G. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?. Circ Res 91 (2002) 652-655
51. Hu Y., Zhang Z., Torsney E., Afzal A.R., Davison F., Metzler B., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 113 (2004) 1258-1265
52. Shi Y., O'Brien J.E., Fard A., Mannion J.D., Wang D., and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
53. Torsney E., Hu Y., and Xu Q. Adventitial progenitor cells contribute to arteriosclerosis. Trends Cardiovasc Med 15 (2005) 64-68
54. Michel J.B., Thaunat O., Houard X., Meilhac O., Caligiuri G., and Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 27 (2007) 1259-1268
55. Schoneveld A.H., Oude Nijhuis M.M., van Middelaar B., Laman J.D., de Kleijn D.P., and Pasterkamp G. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res 66 (2005) 162-169
56. Vink A., Schoneveld A.H., van der Meer J.J., van Middelaar B.J., Sluijter J.P., Smeets M.B., et al. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106 (2002) 1985-1990
57. Jiang Z, Yu P, Tao M, Fernandez C, Ifantides C, Moloye O, et al. TGF-{beta}/CTGF mediated fibroblast recruitment influences early outward vein graft remodeling. Am J Physiol Heart Circ Physiol in press, doi:10.1152/ajpheart.01372.2006 (available online 16 March 2007).
58. Faber J.E., and Yang N. Balloon injury alters alpha-adrenoceptor expression across rat carotid artery wall. Clin Exp Pharmacol Physiol 33 (2006) 204-210
59. Davie N.J., Gerasimovskaya E.V., Hofmeister S.E., Richman A.P., Jones P.L., Reeves J.T., et al. Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. Am J Pathol 168 (2006) 1793-1807
60. Dubrovska G., Verlohren S., Luft F.C., and Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol 286 (2004) H1107-H1113
61. Lohn M., Dubrovska G., Lauterbach B., Luft F.C., Gollasch M., and Sharma A.M. Periadventitial fat releases a vascular relaxing factor. Faseb J 16 (2002) 1057-1063
62. Gao Y.J., Zeng Z.H., Teoh K., Sharma A.M., Abouzahr L., Cybulsky I., et al. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg 130 (2005) 1130-1136
63. Singhal A., Farooqi I.S., Cole T.J., O'Rahilly S., Fewtrell M., Kattenhorn M., et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation 106 (2002) 1919-1924
64. Whincup P.H., Gilg J.A., Donald A.E., Katterhorn M., Oliver C., Cook D.G., et al. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation 112 (2005) 1789-1797
65. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E, et al. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis in press, doi:10.1016/j.atherosclerosis.2007.01.040 (available 28 March 2007).
66. Cavallotti C., Bruzzone P., and Mancone M. Catecholaminergic nerve fibers and beta-adrenergic receptors in the human heart and coronary vessels. Heart Vessels 17 (2002) 30-35
67. Crick S.J., Wharton J., Sheppard M.N., Royston D., Yacoub M.H., Anderson R.H., and Polak J.M. Innervation of the human cardiac conduction system. A quantitative immunohistochemical and histochemical study. Circulation 89 (1994) 1697-16708
68. Dahlstrom A., Mya-Tu M., Fuxe K., and Zetterstrom B.E. Observations on adrenergic innervation of dog heart. Am J Physiol 209 (1965) 689-692
69. Aubineau P. [Role of the adventitial innervation in establishing and maintaining the structural and functional properties of the arterial wall. Effects during aging]. Ann Cardiol Angeiol (Paris) 40 (1991) 285-291
70. Gonzalez C., Barroso C., Martin C., Gulbenkian S., and Estrada C. Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries. J Cereb Blood Flow Metab 17 (1997) 977-984
71. Okamura T., Ayajiki K., Fujioka H., Shinozaki K., and Toda N. Neurogenic cerebral vasodilation mediated by nitric oxide. Jpn J Pharmacol 88 (2002) 32-38
72. Yu J.G., Kimura T., Chang X.F., and Lee T.J. Segregation of vipergic-nitric oxidergic and cholinergic-nitric oxidergic innervation in porcine middle cerebral arteries. Brain Res 801 (1998) 78-87
73. Kadowitz P.J., Knight D.S., Hibbs R.G., Ellison J.P., Joiner P.D., Brody M.J., et al. Influence of 5- and 6-hydroxydopamine on adrenergic transmission and nerve terminal morphology in the canine pulmonary vascular bed. Circ Res 39 (1976) 191-199
74. Knoche H., Walther-Wenke G., and Addicks K. [The fine structure of baroreceptor's nerve endings in the wall of carotid sinus in cats]. Acta Anat (Basel) 97 (1977) 403-418
75. Okamura T., Ayajiki K., Uchiyama M., Kagami K., and Toda N. Mechanisms underlying constrictor and dilator responses to perivascular nerve stimulation in canine lingual arteries. Eur J Pharmacol 354 (1998) 43-50
76. Toda N., Kimura T., Yoshida K., Bredt D.S., Snyder S.H., Yoshida Y., et al. Human uterine arterial relaxation induced by nitroxidergic nerve stimulation. Am J Physiol 266 (1994) H1446-H1450
77. Bevan R.D., Dodge J., Nichols P., Penar P.L., Walters C.L., Wellman T., et al. Weakness of sympathetic neural control of human pial compared with superficial temporal arteries reflects low innervation density and poor sympathetic responsiveness. Stroke 29 (1998) 212-221
78. Ralevic V., and Burnstock G. Neural-endothelial interactions in the control of local vascular tone (1993), Landes, Austin, TX
79. Bennett M.R., Farnell L., Gibson W.G., and Blair D. A quantitative description of the diffusion of noradrenaline in the media of blood vessels following its release from sympathetic varicosities. J Theor Biol 226 (2004) 359-372
80. Edvinsson L., Gulbenkian S., Wharton J., Jansen I., and Polak J.M. Peptide-containing nerves in the rat femoral artery and vein. An immunocytochemical and vasomotor study. Blood Vessels 26 (1989) 254-271
81. Reinecke M., Weihe E., Carraway R.E., Leeman S.E., and Forssmann W.G. Localization of neurotensin immunoreactive nerve fibers in the guinea-pig heart: evidence derived by immunohistochemistry, radioimmunoassay and chromatography. Neuroscience 7 (1982) 1785-1795
82. Dimitriadou V., Henry P., Brochet B., Mathiau P., and Aubineau P. Cluster headache: ultrastructural evidence for mast cell degranulation and interaction with nerve fibres in the human temporal artery. Cephalalgia 10 (1990) 221-228
83. Karimi K., Kool M., Nijkamp F.P., and Redegeld F.A. Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells. Eur J Pharmacol 489 (2004) 49-54
84. Wang H.D., Pagano P.J., Du Y., Cayatte A.J., Quinn M.T., Brecher P., and Cohen R.A. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82 (1998) 810-818
85. Grenier G., Remy-Zolghadri M., Bergeron F., Guignard R., Baker K., Labbe R., Auger F.A., and Germain L. Mechanical loading modulates the differentiation state of vascular smooth muscle cells. Tissue Eng 12 (2006) 3159-3170
86. Balakumar P., Singh A.P., and Singh M. Rodent models of heart failure. J Pharmacol Toxicol Methods 56 (2007) 1-10
87. Davidson M.K., Lindsey J.R., and Davis J.K. Requirements and selection of an animal model. Isr J Med Sci 23 (1987) 551-555
88. Loisel S., Ohresser M., Pallardy M., Dayde D., Berthou C., Cartron G., and Watier H. Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment. Crit Rev Oncol Hematol 62 (2007) 34-42
89. Rangarajan A., Hong S.J., Gifford A., and Weinberg R.A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6 (2004) 171-183
90. Tkacs N.C., and Thompson H.J. From bedside to bench and back again: research issues in animal models of human disease. Biol Res Nurs 8 (2006) 78-88
91. Auger F.A. The LOEX perspective on the role of tissue engineering in regenerative medicine. Biomed Mater Eng 16 (2006) S19-S25
92. Diebolt M, Laflamme K, Labbé R, Germain L, Auger FA, Andriantsitohaina R. Polyphenols modulate calcium-independent mechanisms in human arterial tissue-engineered vascular media. J Vasc Surg 2007; in press.
93. Griffith L.G., and Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7 (2006) 211-224
94. Suuronen E.J., Sheardown H., Newman K.D., McLaughlin C.R., and Griffith M. Building in vitro models of organs. Int Rev Cytol 244 (2005) 137-173
95. Germain L., Remy-Zolghadri M., and Auger F. Tissue engineering of the vascular system: from capillaries to larger blood vessels. Med Biol Eng Comput 38 (2000) 232-240
96. Onoue H., Tsutsui M., Smith L., O'Brien T., and Katusic Z.S. Adventitial expression of recombinant endothelial nitric oxide synthase gene reverses vasoconstrictor effect of endothelin-1. J Cereb Blood Flow Metab 19 (1999) 1029-1037
97. Davenport A.P., and Maguire J.J. Endothelin. Handb Exp Pharmacol (2006) 295-329
98. Turner A.J., and Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. Faseb J 11 (1997) 355-364
99. Turner A.J., and Murphy L.J. Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51 (1996) 91-102
100. D'Orleans-Juste P., Plante M., Honore J.C., Carrier E., and Labonte J. Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol 81 (2003) 503-510
101. Somoza B., Gonzalez M.C., Gonzalez J.M., Abderrahim F., Arribas S.M., and Fernandez-Alfonso M.S. Modulatory role of the adventitia on noradrenaline and angiotensin II responses role of endothelium and AT2 receptors. Cardiovasc Res 65 (2005) 478-486
102. Klein C.L., Scholl M., and Maelicke A. Neuronal networks in vitro: formation and organization on biofunctionalized surfaces. J Mater Sci Mater Med 10 (1999) 721-727
103. Ikeda R., Kurokawa M.S., Chiba S., Yoshikawa H., Hashimoto T., Tadokoro M., et al. Transplantation of motoneurons derived from MASH1-transfected mouse ES cells reconstitutes neural networks and improves motor function in hemiplegic mice. Exp Neurol 189 (2004) 280-292
104. Gingras M., Paradis I., and Berthod F. Nerve regeneration in a collagen-chitosan tissue-engineered skin transplanted on nude mice. Biomaterials 24 (2003) 1653-1661
105. Gingras M., Champigny M.F., and Berthod F. Differentiation of human adult skin-derived neuronal precursors into mature neurons. J Cell Physiol 210 (2007) 498-506
106. Hudon V., Berthod F., Black A.F., Damour O., Germain L., and Auger F.A. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br J Dermatol 148 (2003) 1094-1104